178 related articles for article (PubMed ID: 21285103)
1. Valproate prescription prevalence among women of childbearing age.
Wisner KL; Leckman-Westin E; Finnerty M; Essock SM
Psychiatr Serv; 2011 Feb; 62(2):218-20. PubMed ID: 21285103
[TBL] [Abstract][Full Text] [Related]
2. A UK clinical audit addressing the quality of prescribing of sodium valproate for bipolar disorder in women of childbearing age.
Paton C; Cookson J; Ferrier IN; Bhatti S; Fagan E; Barnes TRE
BMJ Open; 2018 Apr; 8(4):e020450. PubMed ID: 29654033
[TBL] [Abstract][Full Text] [Related]
3. [Prescribing valproate to girls and women of childbearing age in Germany : Analysis of trends based on claims data].
Wentzell N; Haug U; Schink T; Engel S; Liebentraut J; Linder R; Onken M; Schaefer C; Dathe K
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Aug; 61(8):1022-1029. PubMed ID: 29922910
[TBL] [Abstract][Full Text] [Related]
4. Valproate prescription to women of childbearing age in English primary care: repeated cross-sectional analyses and retrospective cohort study.
Gaudio M; Konstantara E; Joy M; van Vlymen J; de Lusignan S
BMC Pregnancy Childbirth; 2022 Jan; 22(1):73. PubMed ID: 35086478
[TBL] [Abstract][Full Text] [Related]
5. Sodium valproate prescription to women of childbearing age in a New Zealand inpatient psychiatric unit.
Goldspink R; Pumipi T; Dey S; Menkes DB
Australas Psychiatry; 2020 Oct; 28(5):555-558. PubMed ID: 32586113
[TBL] [Abstract][Full Text] [Related]
6. Use of valproate in women of childbearing potential: pre- and post-NICE bipolar guidelines.
Vasudev K; Mead A
Arch Womens Ment Health; 2010 Aug; 13(4):371-2. PubMed ID: 20440523
[No Abstract] [Full Text] [Related]
7. Reproductive function and risk for PCOS in women treated for bipolar disorder.
Rasgon NL; Altshuler LL; Fairbanks L; Elman S; Bitran J; Labarca R; Saad M; Kupka R; Nolen WA; Frye MA; Suppes T; McElroy SL; Keck PE; Leverich G; Grunze H; Walden J; Post R; Mintz J
Bipolar Disord; 2005 Jun; 7(3):246-59. PubMed ID: 15898962
[TBL] [Abstract][Full Text] [Related]
8. Menstrual abnormalities and polycystic ovary syndrome in women taking valproate for bipolar mood disorder.
O'Donovan C; Kusumakar V; Graves GR; Bird DC
J Clin Psychiatry; 2002 Apr; 63(4):322-30. PubMed ID: 12000206
[TBL] [Abstract][Full Text] [Related]
9. Evolution and characteristics of the use of valproate in women of childbearing age with bipolar disorder: Results from the FACE-BD cohort.
Samalin L; Godin O; Olié E; Etain B; Henry C; Pelletier A; Poinso F; Encely L; Mazer N; Roux P; Loftus J; Gard S; Bennabi D; Polosan M; Schwitzer T; Aubin V; Schwan R; Passerieux C; Bougerol T; Dubertret C; Aouizerate B; Haffen E; Courtet P; Bellivier F; Leboyer M; ; Llorca PM; Belzeaux R
J Affect Disord; 2020 Nov; 276():963-969. PubMed ID: 32745833
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal follow-up of reproductive and metabolic features of valproate-associated polycystic ovarian syndrome features: A preliminary report.
Joffe H; Cohen LS; Suppes T; Hwang CH; Molay F; Adams JM; Sachs GS; Hall JE
Biol Psychiatry; 2006 Dec; 60(12):1378-81. PubMed ID: 16950230
[TBL] [Abstract][Full Text] [Related]
11. Polycystic ovary syndrome in women using valproate: a review.
Bilo L; Meo R
Gynecol Endocrinol; 2008 Oct; 24(10):562-70. PubMed ID: 19012099
[TBL] [Abstract][Full Text] [Related]
12. 'Conceivably Neglected' - Are prescribers sufficiently aware of the risks of prescribing sodium valproate to women with mental illness?
Perera C; Patterson S; Bruxner G
Australas Psychiatry; 2019 Apr; 27(2):125-128. PubMed ID: 30763123
[TBL] [Abstract][Full Text] [Related]
13. The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study.
Gau SS; Chao PF; Lin YJ; Chang CJ; Gau CS
J Clin Psychopharmacol; 2008 Oct; 28(5):509-17. PubMed ID: 18794645
[TBL] [Abstract][Full Text] [Related]
14. Changes in body weight and body mass index among psychiatric patients receiving lithium, valproate, or topiramate: an open-label, nonrandomized chart review.
Chengappa KN; Chalasani L; Brar JS; Parepally H; Houck P; Levine J
Clin Ther; 2002 Oct; 24(10):1576-84. PubMed ID: 12462287
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic evidence for manic episode].
Terao T
Seishin Shinkeigaku Zasshi; 2011; 113(9):867-72. PubMed ID: 22117391
[TBL] [Abstract][Full Text] [Related]
16. Changes in use of valproate and other mood stabilizers for patients with schizophrenia from 1994 to 1998.
Citrome L; Levine J; Allingham B
Psychiatr Serv; 2000 May; 51(5):634-8. PubMed ID: 10783182
[TBL] [Abstract][Full Text] [Related]
17. Bipolar disorder and valproate-induced hyperammonemic encephalopathy in an adolescent with diabetes.
Young L; Coffey BJ
J Child Adolesc Psychopharmacol; 2010 Oct; 20(5):449-52. PubMed ID: 20973717
[No Abstract] [Full Text] [Related]
18. Longitudinal evaluation of reproductive function in women treated for bipolar disorder.
Rasgon NL; Reynolds MF; Elman S; Saad M; Frye MA; Bauer M; Altshuler LL
J Affect Disord; 2005 Dec; 89(1-3):217-25. PubMed ID: 16171873
[TBL] [Abstract][Full Text] [Related]
19. The valproate serum level in maintenance therapy for bipolar disorder in Japan.
Machino A; Jitsuiki H; Okamoto Y; Izumitani S; Kimura Y; Suzuki K; Tanaka T; Inoue T; Koyama T; Wada K; Masaoka Y; Sasaki T; Yoshimura R; Nakamura J; Sumitan S; Ohmori T; Yamawaki S
Hiroshima J Med Sci; 2013 Mar; 62(1):7-12. PubMed ID: 23600328
[TBL] [Abstract][Full Text] [Related]
20. Valproate prescriptions for nonepilepsy disorders in reproductive-age women.
Adedinsewo DA; Thurman DJ; Luo YH; Williamson RS; Odewole OA; Oakley GP
Birth Defects Res A Clin Mol Teratol; 2013 Jun; 97(6):403-8. PubMed ID: 23733498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
